Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[New challenges in multiple sclerosis treatment].
Autoimmune Demyelinating Polyneuropathy as a Manifestation of Chronic Graft-versus-Host Disease after Adult Cord Blood Transplantation in a Patient with Chronic Lymphocytic Leukemia.
Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor.
Neuromyelitis optica: a positive appraisal of seronegative cases.
Multiple sclerosis: Biomarkers predict conversion from clinically isolated syndrome to multiple sclerosis.
Neurotoxocarosis alters myelin protein gene transcription and expression.
Bladder dysfunction and quality of life for people with multiple sclerosis.
Degradation of polyomavirus JC T-antigen by stress involves the LIP isoform of C/EBP.
Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study.
Consequences of neurologic lesions assessed by Barthel Index after Botox(®) injection may be underestimated.
Alpha beta-crystallin expression and presentation following infection with murine gammaherpesvirus 68.
Detecting multiple autoantibodies to diagnose autoimmune co-morbidity (multiple autoimmune syndromes and overlap syndromes): a challenge for the autoimmunologist.
Reply: Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration.
The Development of Prophylactic and Therapeutic EBV Vaccines.
The role of N-Glycan modification of TNFR1 in inflammatory microglia activation.
Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity.
The Central Role of Neuroscientists under National Socialism.
Response to: Tocilizumab, neuromyelitis optica (NMO), and multiple sclerosis.
Combined central and peripheral demyelination: A case description.
IFN-γ-induced apoptosis of human embryonic stem cell derived oligodendrocyte progenitor cells is restricted by CXCR2 signaling.
Increased sleep fragmentation in experimental autoimmune encephalomyelitis.
Lipoprotein-associated lysolipids are differentially involved in high-density lipoprotein- and its oxidized form-induced neurite remodeling in PC12 cells.
Atypical MRI features at early onset natalizumab-associated progressive multifocal leukoencephalopathy: A case report.
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.
[Sympathetic skin response and multiple sclerosis: Descriptive and prospective study, and association with neuroperineal disorders].
Pages
« first
‹ previous
…
563
564
565
566
567
568
569
570
571
…
next ›
last »